Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dayer

Showing results (21-30 of 163) with videos related to

Pageof 17
Sort By:
Therapeutische Umschau. Revue Therapeutique|December 1, 1985
[Drug interactions in the elderly]J Fabre, P Dayer, T Leemann
Schweizerische Medizinische Wochenschrift|March 19, 1977
[Potassium chloride and non-specific ulcers in the small intestine]P Dayer, P Cech, B Courvosier
Revue Medicale Suisse|May 19, 2005
[The selection of a drug in a defined therapeutic class: the case of the HMG-CoA reductase inhibitors]F Girardin, J Desmeules, P Dayer
Clinical Pharmacokinetics|March 1, 1985
Clinical pharmacokinetics of the third generation cephalosporinsL Balant, P Dayer, R Auckenthaler
European Journal of Clinical Pharmacology|March 27, 1998
Lack of acetaminophen ceiling effect on R-III nociceptive flexion reflexV Piguet, J Desmeules, P Dayer
Life Sciences|January 1, 1994
Selective inhibition of major drug metabolizing cytochrome P450 isozymes in human liver microsomes by carbon monoxideT Leemann, P Bonnabry, P Dayer
International Journal of Clinical Pharmacology Research|January 1, 1983
The genetic control of drug oxidation in the liverP Dayer, L Balant, J Fabre
Drugs|January 1, 1997
[Pharmacology of tramadol]P Dayer, J Desmeules, L Collart
Life Sciences|January 1, 1991
The role of lipophilicity in the inhibition of polymorphic cytochrome P450IID6 oxidation by beta-blocking agents in vitroS Ferrari, T Leemann, P Dayer
European Journal of Clinical Pharmacology|January 1, 1990
Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicamC Benveniste, R Striberni, P Dayer
Pageof 17

Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
Therapeutische Umschau. Revue Therapeutique|December 1, 1985
[Drug interactions in the elderly]J Fabre, P Dayer, T Leemann
Schweizerische Medizinische Wochenschrift|March 19, 1977
[Potassium chloride and non-specific ulcers in the small intestine]P Dayer, P Cech, B Courvosier
Revue Medicale Suisse|May 19, 2005
[The selection of a drug in a defined therapeutic class: the case of the HMG-CoA reductase inhibitors]F Girardin, J Desmeules, P Dayer
Clinical Pharmacokinetics|March 1, 1985
Clinical pharmacokinetics of the third generation cephalosporinsL Balant, P Dayer, R Auckenthaler
European Journal of Clinical Pharmacology|March 27, 1998
Lack of acetaminophen ceiling effect on R-III nociceptive flexion reflexV Piguet, J Desmeules, P Dayer
Life Sciences|January 1, 1994
Selective inhibition of major drug metabolizing cytochrome P450 isozymes in human liver microsomes by carbon monoxideT Leemann, P Bonnabry, P Dayer
International Journal of Clinical Pharmacology Research|January 1, 1983
The genetic control of drug oxidation in the liverP Dayer, L Balant, J Fabre
Drugs|January 1, 1997
[Pharmacology of tramadol]P Dayer, J Desmeules, L Collart
Life Sciences|January 1, 1991
The role of lipophilicity in the inhibition of polymorphic cytochrome P450IID6 oxidation by beta-blocking agents in vitroS Ferrari, T Leemann, P Dayer
European Journal of Clinical Pharmacology|January 1, 1990
Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicamC Benveniste, R Striberni, P Dayer
Pageof 17